Parvex, Willi, Kossovsky, Girardin, pediatric nephrology, Geneva University, Switzerland The...

40
Parvex, Willi, Kossovsky, Girardin, pediatric nephrology, Geneva University, Switzerland The spectrum of renal scarring

Transcript of Parvex, Willi, Kossovsky, Girardin, pediatric nephrology, Geneva University, Switzerland The...

Page 1: Parvex, Willi, Kossovsky, Girardin, pediatric nephrology, Geneva University, Switzerland The spectrum of renal scarring.

Parvex, Willi, Kossovsky, Girardin, pediatric nephrology, Geneva University, Switzerland

The spectrum of renal scarring

Page 2: Parvex, Willi, Kossovsky, Girardin, pediatric nephrology, Geneva University, Switzerland The spectrum of renal scarring.

Background

• UTI is common condition in childhood with a prevalence of 3%, the prevalence of pyelonephritis (PNA) is not clearly reported

• Infant and children presenting unexplained fever of ≥ 38° and positive urine culture will be diagnosed with PNA

Page 3: Parvex, Willi, Kossovsky, Girardin, pediatric nephrology, Geneva University, Switzerland The spectrum of renal scarring.

Background

• The goal of medical management of PNA– Initiate early treatment to decrease renal

inflammation and subsequently scars

– Identify risk factor to avoid new infections

episodes and prevent scars development • Exclude urologic anomalies (renal echography)• Detect vesico-ureteral reflux (cystography)

Page 4: Parvex, Willi, Kossovsky, Girardin, pediatric nephrology, Geneva University, Switzerland The spectrum of renal scarring.

Pathogenesis of scars

• It is important to differentiate acquired segmental scarring associated with VUR and PNA

• From congenital “scars” corresponding to an anomaly in the metanephric development in boys and associated with high grade VUR

• Histological analyses of these later lesions showed renal dysplasia which may mimic scarring without an acute episode of PNA

Page 5: Parvex, Willi, Kossovsky, Girardin, pediatric nephrology, Geneva University, Switzerland The spectrum of renal scarring.

Renal scintigraphy

• Since 1980, renal scintigraphy with TechnetiumTc labeled with dimercapto-succinyl-acid DMSA – replaced IVP and improved in the detection of

renal scars– has been validated to be the most sensitive

method for imaging in the diagnosis of acute PNA and for renal scars

Page 6: Parvex, Willi, Kossovsky, Girardin, pediatric nephrology, Geneva University, Switzerland The spectrum of renal scarring.

Normal kidney Renal scarsAcute PNA

Page 7: Parvex, Willi, Kossovsky, Girardin, pediatric nephrology, Geneva University, Switzerland The spectrum of renal scarring.

What is known form the literature

• Did early antibiotic treatment avoid scar formation?

• How important is the grade of VUR?

• Is the risk to do scars related to age?

• Are scars leading to hypertension (HTA) in adulthood?

Page 8: Parvex, Willi, Kossovsky, Girardin, pediatric nephrology, Geneva University, Switzerland The spectrum of renal scarring.

Early treatment (T)?

• Recent data suggest that if early T decrease renal inflammation in the acute phase

• However in this patients (n=186) early T seems not to decrease the risk of later scars (T<24H or T>24H)

Doganis, D. et al. Pediatrics 2007;120:e922-e928

Page 9: Parvex, Willi, Kossovsky, Girardin, pediatric nephrology, Geneva University, Switzerland The spectrum of renal scarring.

Role of VUR?

• VUR is considered to be the principal risk factor to favor PNA and therefore renal scars

• The incidence of VUR in children presenting PNA varies among studies from 30 to 50%

• Even if scars can develop without VUR or low grade VUR however the risk increased with high grade VUR

Page 10: Parvex, Willi, Kossovsky, Girardin, pediatric nephrology, Geneva University, Switzerland The spectrum of renal scarring.

VUR and severity of scars

Gonzalez et al. The Journal of Urology , Volume 173 , Issue 2 , Pages 571 - 575

Page 11: Parvex, Willi, Kossovsky, Girardin, pediatric nephrology, Geneva University, Switzerland The spectrum of renal scarring.

Age and risk factor

Benador et al Vol 379, January 1997, Pages 17-19

Page 12: Parvex, Willi, Kossovsky, Girardin, pediatric nephrology, Geneva University, Switzerland The spectrum of renal scarring.

Vol 379, January 1997, Pages 17-19

Page 13: Parvex, Willi, Kossovsky, Girardin, pediatric nephrology, Geneva University, Switzerland The spectrum of renal scarring.

HTA

• One of the main concern are further development of hypertension in children presenting scars

• Hypertension affects among series 5-27% of children; however the literature have not showed strong evidence until known

Page 14: Parvex, Willi, Kossovsky, Girardin, pediatric nephrology, Geneva University, Switzerland The spectrum of renal scarring.

• A 15 years follow-up of BP studied 78 Pts with reflux nephropathy

• All were normal BP at time of inclusion

• 18/78 pts became HTA(>95th) during the following 15 years; 6 from them had a family history for HTA

Risk for the future: HTA

Page 15: Parvex, Willi, Kossovsky, Girardin, pediatric nephrology, Geneva University, Switzerland The spectrum of renal scarring.

Systolic and diastolic BP at 5,10,15 years follow-ups

Chulananda et al. Vol 347, March 9,1996

Page 16: Parvex, Willi, Kossovsky, Girardin, pediatric nephrology, Geneva University, Switzerland The spectrum of renal scarring.

• The following recorded 24HBP in 61 pts classified in different groups according to the severity of DMSA lesions

• Type 1: normal reniforme shape but polar area with photon deficiency

• Type 2: focal defect in a nondeformed kidney• Type 3: Smaller kidney compared to controlateral• Type 4a:Loss of renal contour with normal size

kidney• Type 4b:similar from above with small kidney

Risks for the future: HTA

Page 17: Parvex, Willi, Kossovsky, Girardin, pediatric nephrology, Geneva University, Switzerland The spectrum of renal scarring.
Page 18: Parvex, Willi, Kossovsky, Girardin, pediatric nephrology, Geneva University, Switzerland The spectrum of renal scarring.

J Pediatr. Patzer et al 2003 Feb;142(2):117-22.

Is this increase of BP at night a sign of further evolution of HTA in adulthood needs to be confirmed by long term studies

Page 19: Parvex, Willi, Kossovsky, Girardin, pediatric nephrology, Geneva University, Switzerland The spectrum of renal scarring.

What is the long

term significance of scars?

Page 20: Parvex, Willi, Kossovsky, Girardin, pediatric nephrology, Geneva University, Switzerland The spectrum of renal scarring.

Background

• The presence of lesions on DMSA 6 month after PNA are considered to be definitive kidney scars

• According to the literature the rate of acute lesions and later scars varies among studies

Page 21: Parvex, Willi, Kossovsky, Girardin, pediatric nephrology, Geneva University, Switzerland The spectrum of renal scarring.
Page 22: Parvex, Willi, Kossovsky, Girardin, pediatric nephrology, Geneva University, Switzerland The spectrum of renal scarring.

Questions?

• Did these lesions still have the potential to evolve after 6 month

• Did this lesions interfere with normal renal growth

Page 23: Parvex, Willi, Kossovsky, Girardin, pediatric nephrology, Geneva University, Switzerland The spectrum of renal scarring.

Aim of the study

• To analyze long term progression of renal lesions in children with presence of scars on the first DMSA

• To assess long term renal growth

• To identify variables which could impact on renal growth in this children

Page 24: Parvex, Willi, Kossovsky, Girardin, pediatric nephrology, Geneva University, Switzerland The spectrum of renal scarring.

Material

• This prospective study was conducted over two years and included

• Children from 0-18 years with a diagnosis of PNA and who presented renal scars 6 month after the first episode of PNA

• Exclusion criteria • Children with complex uro-genital malformations,

dysplastic kidneys, megaurether, hydronephrosis

Page 25: Parvex, Willi, Kossovsky, Girardin, pediatric nephrology, Geneva University, Switzerland The spectrum of renal scarring.

Methods

• Each patient with scars was contacted to have a repeated DMSA 3 years later

• At the same time we repeated a renal echography to measure kidney size

Page 26: Parvex, Willi, Kossovsky, Girardin, pediatric nephrology, Geneva University, Switzerland The spectrum of renal scarring.

• To analyze progression

of DMSA defects,

RU was divided in 3 areas

• Scar progression was analyzed separately for each area by 3 observers in a blinded fashion and classified as follow– No change– Partial resolution– Total disappearance

Upper pole

Mid zone

Lower pole

Page 27: Parvex, Willi, Kossovsky, Girardin, pediatric nephrology, Geneva University, Switzerland The spectrum of renal scarring.

b

1A 1B

a

b

a

b

2A

2B

2A DMSA 6 month 2B DMSA 3 years later: we observe a) disappearance of mid-zone lesion of left kidney b) no change in lower lesion of right kidney

1A DMSA 6 month after PNA 1B DMSA 3 years later: we observe 2 types of lesions: a) the lesion situated in the mid-zone of left kidney did not change b) The lesion located in the right upper pole improved.

a

2A

a

b

Parvex et al The Journal of Urology on Press

Page 28: Parvex, Willi, Kossovsky, Girardin, pediatric nephrology, Geneva University, Switzerland The spectrum of renal scarring.

(cm)

Kidney growth

Kidney size was measured Time 0 corresponding to the PNA (T0) and 3 years later Time 3 (T3) at the same time of the repeated DMSA

Page 29: Parvex, Willi, Kossovsky, Girardin, pediatric nephrology, Geneva University, Switzerland The spectrum of renal scarring.

• Renal size was measured at T0 and T 3 and values compared to standard deviation score (SDS ) renal sizes* relative to age

• The following equation were used*to calculate Z-score– *<1 year length (cm)= 4.98+0.55 x age(mths)(t90 = 6.86,

p<0.001;SD=0.69;r2=0.3437– *≥ 1 year length (cm)= 6.79+0.22 x age(years)(t326 = 28,

<0.001;SD=0.79;r2=0.7077

• Renal growth between T0 and T3 was calculated with the ∆z-score

• = or + ∆z-score correspond to adequate renal growth• - ∆z-score correspond in loss of renal growth

*AJR Am J Roentgenol 1984;142(3):467-9.

Page 30: Parvex, Willi, Kossovsky, Girardin, pediatric nephrology, Geneva University, Switzerland The spectrum of renal scarring.

Results

• 50 (30G:20B) children; M age of 4.1

• Boys were younger 15/20 ≤2years(75%) against 9/30 (30%) girls

• VUR was present in 36% of patients and 25% of renal units (RU)

Page 31: Parvex, Willi, Kossovsky, Girardin, pediatric nephrology, Geneva University, Switzerland The spectrum of renal scarring.

100 Renal units (RU)

VUR in 25 RU (25%)

No VUR in 75 RU (75%)

13 Low-grade VUR (52%)

12 High-grade VUR (48%)

11 VUR corrected

after 3 years (85%)

2 VUR persists after 3 years

(15%)

2 VUR had Deflux (15%)

9 VUR resolved

(69%)

2 VUR persits after 3 years

(16%)

10 VUR operared

(83%)

2 VUR had Deflux 

8 VUR had Cohen

T0

T3

Incidence and evolution of VUR

Page 32: Parvex, Willi, Kossovsky, Girardin, pediatric nephrology, Geneva University, Switzerland The spectrum of renal scarring.

Number of scars & Grade of VUR

0

1

2

3

4

NO VUR VUR GI-II VUR GIII-IV

P=0.01

Num

ber

of s

cars

Parvex et al The Journal of Urology in Press

Page 33: Parvex, Willi, Kossovsky, Girardin, pediatric nephrology, Geneva University, Switzerland The spectrum of renal scarring.

Progression of renal scars

0

10

20

30

40

50

60

No change total

disappearance

% s

car

imp

rove

me

nt

no change partial improvement total disappearance

27% 63%

9%

Altogether 72% of lesions improved over 3 years

Page 34: Parvex, Willi, Kossovsky, Girardin, pediatric nephrology, Geneva University, Switzerland The spectrum of renal scarring.

Table1: Univariate linear regression analysis of the association between the numbers of defects and renal growth (coefficient=∆ z-score)

Analyze Coefficient ∆z-score

Significance (p) 95% conf. interval

1 defect* Reference - -

2 defects -0.32 0.41 -1.09 to 0.45

3 defects -0.81 0.41 -2.75 to 1.14

4 defects -1.59 0.000 -2.10 to -1.09

5 defects -1.73 0.006 -2.94 to -0.51

Parvex et al The Journal of Urology in Press

Impact of scars on kidney growth

Page 35: Parvex, Willi, Kossovsky, Girardin, pediatric nephrology, Geneva University, Switzerland The spectrum of renal scarring.

Analyze coefficient Significance (p) 95% conf. interval

Sex (M vs. F) 0.49 0.14 -0.16 to 1.14

Age (years)≤ 1* (n=13)> 1 to ≤ 4 (n=20)> 5 (n=17)

-0.280.72

0.420.12

-0.41 to 0.96-0.18 to 1.62

Total n° of defects(Per additional defect)

-0.70 <0.001 -1.05 to -0.35

Lesions progression(Improvement vs. no change)

0.70 0.15 -0.26 to 1.66

Grade of VUR at time of PNA No reflux *Grade I or IIGrade III or IV

-0.750.33

0.120.34

-0.21 to 1.72-0.36 to 1.02

Improvement of VUR >3 years (Yes vs. No)

0.25 0.23 -0.17 to 0.67

Persistence of VUR >3 years (Yes vs. No)

-0.70 0.15 -1.67 to 0.30

Surgery (Yes vs. No) 0.25 0.41 -0.36 to 0.86

Table 2: Multivariable analysis of factors associated with renal growth (coefficient = ∆z-score)Parvex et al The Journal of Urology in Press

Page 36: Parvex, Willi, Kossovsky, Girardin, pediatric nephrology, Geneva University, Switzerland The spectrum of renal scarring.

In summary

• The topographic analyses of renal defects over 3 years showed 72% of improvement

• The number of scars were statistically significantly higher in RU with high grade VUR versus low grade or no VUR.

Parvex et al The Journal of Urology in Press

Page 37: Parvex, Willi, Kossovsky, Girardin, pediatric nephrology, Geneva University, Switzerland The spectrum of renal scarring.

• Loss of kidney growth over 3 years was observed

• with an increased number of scars and this was highly significantly >3 scars

• persistence of VUR>3 years

• The kidney growth did not seem affected by• Sexe, age• Grade of VUR• Improvement of DMSA defects

Parvex et al The Journal of Urology in Press

Page 38: Parvex, Willi, Kossovsky, Girardin, pediatric nephrology, Geneva University, Switzerland The spectrum of renal scarring.

Conclusion

• Renal defects seen at 6 month post PNA can still evolve with time and this raise the question of the definition of scars

• From this study preventing additional renal defects seems to be the best way to optimize kidney growth during childhood

Parvex et al The Journal of Urology on Press

Page 39: Parvex, Willi, Kossovsky, Girardin, pediatric nephrology, Geneva University, Switzerland The spectrum of renal scarring.

Open questions and further perspectives

– Improve knowledge of the congenital “scar” associating renal dysplasia and HGVUR

– To define if the best way to prevent renal

lesions in high grade VUR is prophylaxis? surgery?

– Long term studies to assess the risk HTA in scarred kidneys, with decreased renal growth

Page 40: Parvex, Willi, Kossovsky, Girardin, pediatric nephrology, Geneva University, Switzerland The spectrum of renal scarring.

Thanks' for your attention